These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21899858)

  • 1. The value of immunohistochemical expression of BAX in formulating a prognosis for canine cutaneous mast cell tumours.
    Strefezzi Rde F; Kleeb SR; Xavier JG; Fukumasu H; Catão-Dias JL
    J Comp Pathol; 2012 May; 146(4):314-9. PubMed ID: 21899858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptotic intrinsic pathway proteins predict survival in canine cutaneous mast cell tumours.
    Barra CN; Macedo BM; Cadrobbi KG; Pulz LH; Huete GC; Kleeb SR; Xavier JG; Catão-Dias JL; Nishiya AT; Fukumasu H; Strefezzi RF
    Vet Comp Oncol; 2018 Mar; 16(1):E38-E44. PubMed ID: 28608404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Ki67, BCL-2, and COX-2 in canine cutaneous mast cell tumors: association with grading and prognosis.
    Vascellari M; Giantin M; Capello K; Carminato A; Morello EM; Vercelli A; Granato A; Buracco P; Dacasto M; Mutinelli F
    Vet Pathol; 2013 Jan; 50(1):110-21. PubMed ID: 22673539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine subcutaneous mast cell tumour: diagnosis and prognosis.
    Newman SJ; Mrkonjich L; Walker KK; Rohrbach BW
    J Comp Pathol; 2007 May; 136(4):231-9. PubMed ID: 17399734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Ki67, Bax, Bcl-2 and KIT in canine cutaneous mast cell tumours and their relationship with histopathology and prognosis.
    Aytemiz Danyer I; Gürel A
    Acta Vet Hung; 2024 Jan; 71(3-4):183-192. PubMed ID: 38112689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunohistochemical study of vitamin D receptor expression in canine cutaneous mast cell tumours.
    Russell DS; Rassnick KM; Erb HN; Vaughan MM; McDonough SP
    J Comp Pathol; 2010; 143(2-3):223-6. PubMed ID: 20334872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours.
    Meyer A; Gruber AD; Klopfleisch R
    J Comp Pathol; 2013 Jul; 149(1):19-29. PubMed ID: 23276382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Ki67 index with prognosis for intermediate-grade canine cutaneous mast cell tumours.
    Maglennon GA; Murphy S; Adams V; Miller J; Smith K; Blunden A; Scase TJ
    Vet Comp Oncol; 2008 Dec; 6(4):268-74. PubMed ID: 19178685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canine cutaneous and subcutaneous mast cell tumours: a narrative review.
    Bellamy E; Berlato D
    J Small Anim Pract; 2022 Jul; 63(7):497-511. PubMed ID: 34671978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD25 is expressed by canine cutaneous mast cell tumors but not by cutaneous connective tissue mast cells.
    Meyer A; Gruber AD; Klopfleisch R
    Vet Pathol; 2012 Nov; 49(6):988-97. PubMed ID: 22446323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of immunohistochemical markers in canine cutaneous mast cell tumours: A systematic review and meta-analysis.
    Freytag JO; Queiroz MR; Govoni VM; Pereira IVA; Pulz LH; de Francisco Strefezzi R; Queiroga FL; Cogliati B
    Vet Comp Oncol; 2021 Sep; 19(3):529-540. PubMed ID: 33724647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical application of an antibody specific for human CD1a to the diagnosis of canine mast cell tumour.
    Yhee JY; Hong SW; Yu CH; Doster AR; Blas-Machado U; Lyoo YS; Sur JH
    J Comp Pathol; 2008 Jul; 139(1):40-6. PubMed ID: 18602642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of serotonin and its 5-HT1A receptor in canine cutaneous mast cell tumours.
    Fröberg GK; Lindberg R; Ritter M; Nordlind K
    J Comp Pathol; 2009; 141(2-3):89-97. PubMed ID: 19446835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine cutaneous mast cell tumors: A combined clinical and pathologic approach to diagnosis, prognosis, and treatment selection.
    Sledge DG; Webster J; Kiupel M
    Vet J; 2016 Sep; 215():43-54. PubMed ID: 27372911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the proteome of high-grade versus low-grade canine cutaneous mast cell tumours.
    Schlieben P; Meyer A; Weise C; Bondzio A; Einspanier R; Gruber AD; Klopfleisch R
    Vet J; 2012 Nov; 194(2):210-4. PubMed ID: 22578690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical Expression of the Pluripotency Factor OCT4 in Canine Mast Cell Tumours.
    Vargas TH; Pulz LH; Barra CN; Kleeb SR; Xavier JG; Catão-Dias JL; Fukumasu H; Nishiya AT; Strefezzi RF
    J Comp Pathol; 2015 Nov; 153(4):251-5. PubMed ID: 26460092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic grading of canine mast cell tumor: is 2 better than 3?
    Sabattini S; Scarpa F; Berlato D; Bettini G
    Vet Pathol; 2015 Jan; 52(1):70-3. PubMed ID: 24513799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of intratumoral vessel density in cutaneous mast cell tumors of the dog.
    Preziosi R; Sarli G; Paltrinieri M
    J Comp Pathol; 2004; 130(2-3):143-51. PubMed ID: 15003472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
    Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
    Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of the mitotic index as a prognostic factor for survival of canine cutaneous mast cell tumors: a validation study.
    Elston LB; Sueiro FA; Cavalcanti JN; Metze K
    Vet Pathol; 2009 Mar; 46(2):362-4, author reply 364-5. PubMed ID: 19261652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.